SOLICITATION NOTICE
Q -- SARS-CoV2 3CL protease cell-based assay development for drug screening
- Notice Date
- 6/5/2020 4:17:14 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95020Q00142
- Response Due
- 6/11/2020 8:59:00 AM
- Archive Date
- 06/26/2020
- Point of Contact
- Kimberly Espinosa, Phone: 301-827-3546
- E-Mail Address
-
kimberly.espinosa@nih.gov
(kimberly.espinosa@nih.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires SARS-CoV2 3CL protease cell-based assay development for drug screening to support efforts related to COVID-19. This requirement includes assay development, stable cell line generation and selection by luciferase activity as outlined in the Statement of Work. See attached CSS and�Statement of Work.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/64475df9ce3c4c9590e2b3a925cb1167/view)
- Record
- SN05681830-F 20200607/200605230143 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |